MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » MassDevice podcast: Echo Therapeutics CEO Dr. Patrick Mooney

MassDevice podcast: Echo Therapeutics CEO Dr. Patrick Mooney

By

Dr. Patrick Mooney took an interesting path to the top seat at Echo Therapeutics Inc. (OTC:ECTE), a Philadelphia, Pa.-based company developing a non-invasive, wireless, transdermal continuous glucose monitoring device for the diabetes market.

Mooney, 42, was a surgeon by training before he left medicine for the world of high finance and Wall Street, where he was a biotech analyst for Thomas Weisel Partners LLC and Janney Montgomery Scott. Lured back to the field in 2004 to run biopharmaceutical Aphton Corp. (NSDQ:APHT) for two years, in 2007 Mooney saw something that piqued his interest glinting in the ashes of Sontra Medical — a defunct MIT spinout went for broke developing a next-generation glucose monitoring device.

Click here to listen to MassDevice’s interview with Echo Therapeutics CEO Dr. Patrick Mooney. You can also download an MP3 of the interview by right-clicking.

Sontra, launched in 1998 in Franklin, Mass., went belly-up in December 2006. Mooney said he was attracted by the technology’s pedigree — it came out of Robert Langer’s lab at MIT — and felt that there was still plenty of meat on the bones.

“We saw this play at Sontra and said, ‘Wait a minute, how bad can this be? You have one of the smartest guys in engineering in the world. It’s FDA-approved. We know the technology works. It’s kind of an easy re-do,'” he told MassDevice.

Mooney merged Sontra Medical into Echo Therapeutics in the fall of 2007 and has run the company ever since.

In March, the company reported mixed earnings results for 2010. It had full-year losses of $4.3 million, or 15 cents per diluted share, on sales of $428,460. That compares with losses of $13.5 million, or 61 cents per diluted share, on revenue of $1.3 million in 2009.

Mooney told MassDevice about the Echo story, the company’s Symphony technology and how he hopes to take advantage of the huge opportunity in the diabetes space once the system is commercialized.

Click here to listen to MassDevice’s interview with Echo Therapeutics CEO Dr. Patrick Mooney. You can also download an MP3 of the interview by right-clicking.

In case you missed it

RSS From Medical Design & Outsourcing

  • Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list
    Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of the largest public corporations around. Companies were judged with… […]
  • HHS reports 63-fold increase in telehealth use during pandemic
    A new study from the U.S. Department of Health and Human Services found a 63-fold increase in Medicare telehealth use during the COVID-19 pandemic. The report analyzed Medicare fee-for-service data from 2019 and 2020 and highlighted that people in urban areas were more likely to seek and use telehealth services than rural residents. In addition,… […]
  • Carlyle makes a significant investment in Resonetics
    Carlyle-managed funds have acquired a significant interest in medical device contract manufacturer Resonetics. Today’s announcement did not include the investment size, but the deal values Nashua, New Hampshire–based Resonetics at roughly  $2.25 billion. Carlyle joins existing investor GTCR as a meaningful shareholder in the company. Resonetics focuses on producing highly technical components for medical device… […]
  • Interpreting Pump Performance Curves
    Reading pump performance curves is crucial to proper pump selection. This piece reviews the creation and use of diaphragm pump performance curves to determine flow at given vacuum or pressure conditions. Included is a lesser-known method to interpolate pump performance when flow restrictions exist on both the inlet and outlet sides of the pump. Download… […]
  • BD elaborates on diversity and equity goals
    BD (NYSE:BDX) earlier this week outlined its efforts this year related to global inclusion, diversity and equity. Franklin Lakes, New Jersey-based BD released its 2021 Global Inclusion, Diversity and Equity (ID&E) Report, highlighting the progress it’s made in human health as part of its environmental, social and governance (ESG) strategy, according to a news release.… […]
  • How to protect medical devices from hidden cybersecurity risks
    Your software supply chain could be a cybersecurity risk. Here’s what you can do. Vince Arneja, GrammaTech The healthcare industry has been fighting a war on two fronts during the COVID-19 pandemic against the virus and an outbreak of cyberattacks. The Department of Health and Human Services says the sector reported a 9,851% increase in… […]
  • Integer completes $220M Oscor acquisition
    Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers. Integer said the acquisition would cost $220 million when it first announced its plans in October. Oscor is the creator and marketer… […]
  • Respira Labs seeks FDA clearance for its wearable lung monitor
    Respira Labs recently announced that it has developed a wearable device that continuously assesses lung function without the need for traditional pulmonary function tests. Mountain View, California-based Respira Labs designed its Sylvee wearable initially to assess chronic obstructive pulmonary disease, COVID-19 and asthma patients. It is embedded with speakers and microphones that measure the change… […]
  • Owen Mumford starts work on new production center in U.K.
    Owen Mumford this week announced that it has started building its new production facility in Witney, Oxfordshire in the U.K. Owen Mumford’s new Witney facility will stand as a production site for the company’s recently launched, next-generation auto-injector Aidaptus. The company has decades of experience creating its own drug delivery, blood sampling and rapid diagnostic… […]
  • FDA’s Woodcock reassures about COVID-19 tests, vaccines under Omicron
    Acting FDA Commissioner Dr. Janet Woodcock thinks many COVID-19 tests will continue to work with the new Omicron variant — with information coming soon on vaccine efficacy. In a statement posted yesterday, Woodcock said she thought the agency is well-positioned to work with companies to address the potential impact of viral mutations on COVID-19 tests,… […]
  • Traco Power launches THM 60WI DC-DC converters
    Traco Power today announced it has launched its THM 60WI series of quarter brick DC-DC converters. The Baar, Switzerlad-based company designed the DC-DC converters with ultra-wide input ranges and safety approvals for medical and industrial applications. Traco Power’s THM 60WI series of converters consists of 12 models with 9-75 or 18-75 Vin ranges with single… […]